542 related articles for article (PubMed ID: 19582702)
21. Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome.
Cetković A; Miljic D; Ljubić A; Patterson M; Ghatei M; Stamenković J; Nikolic-Djurovic M; Pekic S; Doknic M; Glišić A; Bloom S; Popovic V
Endocr Res; 2012; 37(2):78-88. PubMed ID: 22489921
[TBL] [Abstract][Full Text] [Related]
22. Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Räty R; Anttila L; Virtanen A; Koskinen P; Laitinen P; Mörsky P; Tiitinen A; Martikainen H; Ekblad U
Prenat Diagn; 2003 Dec; 23(13):1045-8. PubMed ID: 14691989
[TBL] [Abstract][Full Text] [Related]
23. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels.
Florio P; Ciarmela P; Luisi S; Palumbo MA; Lambert-Messerlian G; Severi FM; Petraglia F
Gynecol Endocrinol; 2002 Oct; 16(5):365-72. PubMed ID: 12587530
[TBL] [Abstract][Full Text] [Related]
24. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?
Clausen T; Djurovic S; Reseland JE; Berg K; Drevon CA; Henriksen T
Placenta; 2002 May; 23(5):380-5. PubMed ID: 12061853
[TBL] [Abstract][Full Text] [Related]
25. Mid-trimester triple test levels in early and late onset severe pre-eclampsia.
Shenhav S; Gemer O; Sassoon E; Volodarsky M; Peled R; Segal S
Prenat Diagn; 2002 Jul; 22(7):579-82. PubMed ID: 12124692
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction.
Odibo AO; Sehdev HM; Stamilio DM; Macones GA
Am J Perinatol; 2006 Aug; 23(6):363-7. PubMed ID: 16841275
[TBL] [Abstract][Full Text] [Related]
27. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction.
Egbor M; Ansari T; Morris N; Green CJ; Sibbons PD
BJOG; 2006 May; 113(5):580-9. PubMed ID: 16579806
[TBL] [Abstract][Full Text] [Related]
28. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls.
Farina A; Sekizawa A; Purwosunu Y; Rizzo N; Banzola I; Concu M; Morano D; Giommi F; Bevini M; Mabrook M; Carinci P; Okai T
Prenat Diagn; 2006 Dec; 26(12):1115-20. PubMed ID: 16952198
[TBL] [Abstract][Full Text] [Related]
29. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction.
Hogg BB; Tamura T; Johnston KE; Dubard MB; Goldenberg RL
Am J Obstet Gynecol; 2000 Oct; 183(4):805-9. PubMed ID: 11035317
[TBL] [Abstract][Full Text] [Related]
30. [Sex-hormone binding globulin (SHBG) levels during pregnancy as predictors for pre-eclampsia and fetal growth restriction].
Valdés R E; Lattes A K; Muñoz S H; Cumsille MA
Rev Med Chil; 2012 May; 140(5):589-94. PubMed ID: 23096663
[TBL] [Abstract][Full Text] [Related]
31. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
[TBL] [Abstract][Full Text] [Related]
32. Pre-symptomatic increase in urine-orosomucoid excretion in pre-eclamptic women.
Kronborg CS; Allen J; Vittinghus E; Knudsen UB
Acta Obstet Gynecol Scand; 2007; 86(8):930-7. PubMed ID: 17653877
[TBL] [Abstract][Full Text] [Related]
33. Decreased placental oxygenation capacity in pre-eclampsia: clinical application of a novel index of placental function preformed at the time of delivery.
Matsuo K; Malinow AM; Harman CR; Baschat AA
J Perinat Med; 2009; 37(6):657-61. PubMed ID: 19673683
[TBL] [Abstract][Full Text] [Related]
34. Placental apoptosis and adhesion molecules expression in the placenta and the maternal placental bed of pregnancies complicated by fetal growth restriction with and without pre-eclampsia.
Madazli R; Benian A; Ilvan S; Calay Z
J Obstet Gynaecol; 2006 Jan; 26(1):5-10. PubMed ID: 16390700
[TBL] [Abstract][Full Text] [Related]
35. Increased fetal RhD gene in the maternal circulation in early pregnancy is associated with an increased risk of pre-eclampsia.
Cotter AM; Martin CM; O'Leary JJ; Daly SF
BJOG; 2005 May; 112(5):584-7. PubMed ID: 15842281
[TBL] [Abstract][Full Text] [Related]
36. Pre-eclampsia and peripartum cardiomyopathy in molar pregnancy: clinical implication for maternally imprinted genes.
Billieux MH; Petignat P; Fior A; Mhawech P; Blouin JL; Dahoun S; Vassilakos P
Ultrasound Obstet Gynecol; 2004 Apr; 23(4):398-401. PubMed ID: 15065193
[TBL] [Abstract][Full Text] [Related]
37. Maternal serum soluble adhesion molecule levels at 11+0-13+6 weeks and subsequent development of pre-eclampsia.
Parra-Cordero M; Turan OM; Kaur A; Pearson JD; Nicolaides KH
J Matern Fetal Neonatal Med; 2007 Nov; 20(11):793-6. PubMed ID: 17943642
[TBL] [Abstract][Full Text] [Related]
38. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia.
Tsui DW; Chan KC; Chim SS; Chan LW; Leung TY; Lau TK; Lo YM; Chiu RW
Prenat Diagn; 2007 Dec; 27(13):1212-8. PubMed ID: 17994635
[TBL] [Abstract][Full Text] [Related]
39. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders.
Goetzinger KR; Singla A; Gerkowicz S; Dicke JM; Gray DL; Odibo AO
Am J Obstet Gynecol; 2009 Oct; 201(4):412.e1-6. PubMed ID: 19716535
[TBL] [Abstract][Full Text] [Related]
40. Performance of a novel test to quantify activated protein C resistance in women with a history of pre-eclampsia.
Nap AW; Hamulyak K; van Oerle R; van Pampus LC; Spaanderman ME; Damoiseaux J; Rosing J; Peeters LL
Eur J Obstet Gynecol Reprod Biol; 2004 Mar; 113(1):26-30. PubMed ID: 15036706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
